This webstream addresses the role of the SSbD approach in industrial transformation, exploring opportunities, challenges, and its wider uptake at national and regional levels within the chemical sector.

This webinar presents an overview of frameworks and methodologies for integrating safety and sustainability in the innovation process for nanomaterials, highlighting tools, systems, and platforms compiled in the recent OECD SSbD report.

Recording of a Venice School 2025 session introducing a case-specific, quantitative MCDA approach for SSbD. It features methods for identifying multi-optimal solutions and integrating stakeholder perspectives in decision-making.

This workshop introduces Safe and Sustainable by Design (SSbD) scenarios for advanced and incremental innovations, focusing on tailored approaches for chemical and material risk assessment.

Explore the SUNSHINE e-learning focusing on Safe-and-Sustainable-by-Design (SSbD) for advanced nanomaterials. Access recordings and presentations from workshops, webinars, and annual meetings, offering insights into digital tools and sustainability innovations.

Outlines key concepts in toxicological risk assessment, including critical effects, guidance values, toxicokinetics, and uncertainty factors used in public health decision-making.

Presents Canada’s OHARA initiative to operationalize a One Health approach to risk assessment, emphasizing multisectoral coordination, environmental integration, and protocol development.

Covers the role of industrial toxicology in regulatory compliance, product stewardship, and risk-based evaluation across sectors including chemicals, pharmaceuticals, and consumer goods.

This webinar presents practical tools and expert insights for industrial adoption of the Safe and Sustainable by Design framework, including case studies and approaches to implementation challenges.

The webinar focus on methods to evaluate combined exposures and chemical mixtures, using computer models and in vivo/in vitro testing.

Webinar on stakeholder use of the OECD QSAR Toolbox, with insights from OECD and ECHA on its role in REACH and as an alternative to animal testing for chemical assessment.

Concludes a week-long series of expert discussions with a plenary overview of NanoHarmony’s efforts to support OECD test guideline development, stakeholder collaboration, and long-term regulatory impact for nanosafety.

Discusses the potential of non-animal models to transform safety assessment and therapeutic development, with insights from pandemic-driven advances in regulatory science.